These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 26860753)
1. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Rad E; Tee AR Semin Cell Dev Biol; 2016 Apr; 52():39-46. PubMed ID: 26860753 [TBL] [Abstract][Full Text] [Related]
3. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Ratner N; Miller SJ Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329 [TBL] [Abstract][Full Text] [Related]
4. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448 [TBL] [Abstract][Full Text] [Related]
5. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Williams KB; Largaespada DA Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955 [TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
7. The NF1 somatic mutational landscape in sporadic human cancers. Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487 [TBL] [Abstract][Full Text] [Related]
9. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor. Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromin and suppression of tumorigenesis: beyond the GAP. Mo J; Moye SL; McKay RM; Le LQ Oncogene; 2022 Feb; 41(9):1235-1251. PubMed ID: 35066574 [TBL] [Abstract][Full Text] [Related]
11. Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Park GH; Park E; Lee SJ; Lim K; Kim J; Park JE; Jeong SY Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273214 [TBL] [Abstract][Full Text] [Related]
12. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis. Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697 [TBL] [Abstract][Full Text] [Related]
13. Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome? Fareez F; Wang BH; Brain I; Lu JQ Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237 [TBL] [Abstract][Full Text] [Related]
14. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256 [TBL] [Abstract][Full Text] [Related]
15. The promise of signal transduction in genetically driven sarcomas of the nerve. Kim A; Pratilas CA Exp Neurol; 2018 Jan; 299(Pt B):317-325. PubMed ID: 28859862 [TBL] [Abstract][Full Text] [Related]
16. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. Ozawa T; Araki N; Yunoue S; Tokuo H; Feng L; Patrakitkomjorn S; Hara T; Ichikawa Y; Matsumoto K; Fujii K; Saya H J Biol Chem; 2005 Nov; 280(47):39524-33. PubMed ID: 16169856 [TBL] [Abstract][Full Text] [Related]